Skip to content

Effect of a Neurophenomenological Intervention on Social Anxiety in Adolescents

Neurophenomenological Transformation in Adolescents with Social Anxiety Disorder: Comparing the Effectiveness of a Neural–Embodied Regulation Intervention versus Another Therapeutic Intervention in Improving Interoceptive Markers

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20260107068587N1
Enrollment
38
Registered
2026-01-27
Start date
2026-01-29
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent Social Anxiety Disorder. Social phobias

Interventions

Intervention group: An individual, face-to-face autonomic regulation psychotherapy based on Polyvagal Theory and Somatic Experiencing for adolescents with Social Anxiety Disorder. This intervention is
(2) enhancing interoceptive awareness and identifying bodily anxiety signals
(3) grounding exercises and body-based attentional regulation
(4) autonomic arousal regulation with gradual exposure to age-appropriate social situations
(5) working with threat responses through controlled oscillation between tension and calm states (pendulation)
(6) therapist–client co-regulation and relational repair
(7) integrating felt safety into social interactions through body-based interpersonal exercises
and(8) review, consolidation, and relapse-prevention planning.In selected sessions, brief video-assisted recall is used to facilitate embodied reflection on lived experience and bodily changes. The in

Sponsors

Rah-e Zendegi Psychological Clinics, affiliated with the Imam Khomeini Relief Foundation (IRF)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 18 Years

Inclusion criteria

Inclusion criteria: Formal diagnosis of Social Anxiety Disorder based on DSM-5 criteria using the MINI-KID interview Score of 25 or higher on the Social Anxiety subscale of the SCARED questionnaire Score of 3 or higher on the Pubertal Development Scale as an indicator of entry into the target developmental stage Willingness to participate in the treatment program and adherence until completion of the 8-session protocol No use of psychotropic medications during the past 6 months

Exclusion criteria

Exclusion criteria: History of psychotic disorders Moderate to severe neurodevelopmental disorders Confirmed substance use or substance use disorder

Design outcomes

Primary

MeasureTime frame
Heart rate variability (HRV) as an index of autonomic nervous system regulation, measured by resting RMSSD. Timepoint: Baseline (pre-test; week 0)Post-intervention (post-test; week 3)6-month follow-up after completion of the intervention (approximately week 26). Method of measurement: Heart rate variability is recorded using the BioPac MP150 physiological recording system with a finger photoplethysmography sensor, and the root mean square of successive differences of beat-to-beat intervals is extracted from resting recordings.;Skin conductance level (electrodermal activity) as an index of sympathetic autonomic arousal. Timepoint: Baseline (pre-test; week 0); end of intervention (post-test; week 3); 6-month follow-up after the intervention (approximately week 26). Method of measurement: Skin conductance level will be measured using the BioPac MP150 physiological recording system with silver/silver chloride surface electrodes.

Secondary

MeasureTime frame
Severity of social anxiety symptoms based on the social anxiety subscale score of the Screen for Child and Adolescent Anxiety Related Emotional Disorders questionnaire (SCARED; Birmaher et al., 1999). Timepoint: Baseline (pre-test; week 0); end of intervention (post-test; week 3); six-month follow-up after the intervention (approximately week 26). Method of measurement: Screen for Child and Adolescent Anxiety Related Emotional Disorders questionnaire (SCARED; Birmaher et al., 1999), social anxiety subscale.;Severity of social avoidance based on the social avoidance subscale score of the Screen for Child and Adolescent Anxiety Related Emotional Disorders questionnaire (SCARED; Birmaher et al., 1999). Timepoint: Baseline (pre-test; week 0); end of intervention (post-test; week 3); six-month follow-up after the intervention (approximately week 26). Method of measurement: Screen for Child and Adolescent Anxiety Related Emotional Disorders questionnaire (SCARED; Birmaher et al., 1999), social avoidance subscale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParvaneh Rahmati Sangkar

Imam Khomeini Relief Foundation

parvanehrahmati1383@gmail.com+98 21 2390 2489

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026